Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Laminin γ2–mediating T cell exclusion attenuates response to anti–PD-1 therapy
Lei Li, Jia-Ru Wei, Jun Dong, et al.
Science Advances (2021) Vol. 7, Iss. 6
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts
Xin Li, Tuying Yong, Zhaohan Wei, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 172
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Zengli Fang, Qingcai Meng, Jin Xu, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 3-41
Open Access | Times Cited: 133
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Liping Pei, Yang Liu, Lin Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 115
TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion
Riley Mullins, Ananya Pal, Thomas F. Barrett, et al.
Cancer Research (2022) Vol. 82, Iss. 13, pp. 2329-2343
Open Access | Times Cited: 40
A novel basement membrane-related gene signature for prognosis of lung adenocarcinomas
Zhenxing Zhang, Haoran Zhu, Xiaojun Wang, et al.
Computers in Biology and Medicine (2023) Vol. 154, pp. 106597-106597
Open Access | Times Cited: 34
Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
Yuanzhuo Gu, Zhengkui Zhang, Peter ten Dijke
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 4, pp. 318-340
Open Access | Times Cited: 31
Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy
Jingwen Jiang, Yanjuan Huang, Zishan Zeng, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 843-884
Closed Access | Times Cited: 28
Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
Yiwen Zheng, Shujin Li, Hongchao Tang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis
Shengxin Huang, Dongbing Ding, Tianyun Lan, et al.
Acta Biomaterialia (2023) Vol. 164, pp. 538-552
Closed Access | Times Cited: 26
Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect
Conghua Lu, Ziyuan Gao, Di Wu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e009165-e009165
Open Access | Times Cited: 10
Glycogen metabolism-mediated intercellular communication in the tumor microenvironment influences liver cancer prognosis
YANG ZHANG, NANNAN QIN, Xue‐feng Wang, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 563-576
Open Access | Times Cited: 9
Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer
Yutao Li, Amit Sharma, Ingo G.H. Schmidt‐Wolf
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Extracellular vesicle‐packaged lncRNA from cancer‐associated fibroblasts promotes immune evasion by downregulating HLA‐A in pancreatic cancer
Hanming Yao, Chengzhi Huang, Jinmao Zou, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 8
The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis
Shu‐Hong Yu, Siyu Wang, Xuanyu Wang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts
Xinjie Chen, Guoyu Cheng, Liang Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101576-101576
Open Access | Times Cited: 6
CAFs and T cells interplay: The emergence of a new arena in cancer combat
Minjie Chen, Fei Chen, Zhaofeng Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117045-117045
Open Access | Times Cited: 6
Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironment
Ashley M. Fuller, Hawley C. Pruitt, Ying Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 11
Open Access | Times Cited: 5
The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment
Lanqi Gong, Dora Lai‐Wan Kwong, Wei Dai, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 28
Classification of Non-Small Cell Lung Cancer’s Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade
Alexander Chi, Xia He, Lin Hou, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2924-2924
Open Access | Times Cited: 27
Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect
Yuling Bin, Hongsai Hu, Feng Tian, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 20
Basement membrane promotes tumor development by attenuating T cell activation
Xiangming Liu, Yuemei Qiao, Jianfeng Chen, et al.
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 2
Open Access | Times Cited: 19
Bypassing anti-PD-(L)1 therapy: Mechanisms and management strategies
Keywan Mortezaee, Jamal Majidpoor, Sajad Najafi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114150-114150
Open Access | Times Cited: 19
Identification of a basement membrane gene signature for predicting prognosis and estimating the tumor immune microenvironment in prostate cancer
Tao Xie, Du-Jiang Fu, Kang‐Jing Li, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1581-1604
Open Access | Times Cited: 4
Cancer associated fibroblasts in cancer development and therapy
Hongyuan Jia, Xingmin Chen, Linling Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top